Evidence map›Paper›PMID 38453916›Full record

ArticleNature communications2024

Malaria blood stage infection suppresses liver stage infection via host-induced interferons but not hepcidin.

Hardik Patel, Nana K Minkah, Sudhir Kumar, Gigliola Zanghi, Antonino Schepis, Debashree Goswami, Janna Armstrong, Biley A Abatiyow, Will Betz, Laura Reynolds and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. mRNA-LNP vaccine encoding theMolecular therapy. Nucleic acids · 2025
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Hardik PatelCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.ORCID 0000-0003-0716-4510
Nana K MinkahCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Sudhir KumarCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.ORCID 0000-0002-2847-393X
Gigliola ZanghiCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Antonino SchepisCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Debashree GoswamiCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Janna ArmstrongCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Biley A AbatiyowCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Will BetzCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Laura ReynoldsCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Nelly CamargoCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Amina A SheikhCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Stefan H I KappeCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA. stefan.kappe@seattlechildrens.org.ORCID 0000-0003-1540-1731
Infectious Disease Research Institute · USCenter for Infectious Disease Research · US

Funding

Impairment of anti-Plasmodium T cell memory by type I Interferon SignalingR01AI170777 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI Nana Kwaku Minkah · 2023 to 2026
$3.2M
NIAID NIH HHS R01 AI170777
6 · The paper itself

Abstract

Malaria-causing Plasmodium parasites first replicate as liver stages (LS), which then seed symptomatic blood stage (BS) infection. Emerging evidence suggests that these stages impact each other via perturbation of host responses, and this influences the outcome of natural infection. We sought to understand whether the parasite stage interplay would affect live-attenuated whole parasite vaccination, since the efficacy of whole parasite vaccines strongly correlates with their extend of development in the liver. We thus investigated the impact of BS infection on LS development of genetically attenuated and wildtype parasites in female rodent malaria models and observed that for both, LS infection suffered severe suppression during concurrent BS infection. Strikingly and in contrast to previously published studies, we find that the BS-induced iron-regulating hormone hepcidin is not mediating suppression of LS development. Instead, we demonstrate that BS-induced host interferons are the main mediators of LS developmental suppression. The type of interferon involved depended on the BS-causing parasite species. Our study provides important mechanistic insights into the BS-mediated suppression of LS development. This has direct implications for understanding the outcomes of live-attenuated Plasmodium parasite vaccination in malaria-endemic areas and might impact the epidemiology of natural malaria infection.

Indexed as

Liver DiseasesMalariaMalaria VaccinesPlasmodiumFemaleHepcidinsHumansLiverHepcidinsMalaria Vaccines

Identifiers

PMID38453916
PMCPMC10920859
OpenAlexW4392544550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.